In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Mehra Golshan and Dr. Eric Winer commented on why doctors are calling for a change in the way they treat certain breast cancers.

Tags: BreastCancer

  • Dr. Ursula Matulonis said women diagnosed with ovarian cancer should try to get to a place with gynecologic oncologists and nurses who work with these cancers every day.

Tags: OvarianCancer, Disparities, GynecologicCancers

  • Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.

Tags: LungCancer, Genetics

  • The Savage family moved to Boston from Ireland so that their daughter could be treated by Dana-Farber specialists for a rare form of brain cancer.

Tags: ChildhoodCancer, BrainTumors

  • Dr. Harold Burstein commented on the increase in women opting to undergo preventive bilateral mastectomies.

Tags: BreastCancer

  • A study by Dr. Susan Dale Block found that the less money spent on medical care at the end of a person’s life resulted in a better death experience.

Tags: EndOfLife

  • Dana-Farber President and CEO Dr. Edward J. Benz, Jr., discussed the ongoing war on cancer and where the promising research is now

Tags: BasicResearch, Prevention

  • In a recent national study led by Dr. Jane Weeks, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand that chemotherapy was not at all likely to cure their cancer.

Tags: chemotherapy, EndOfLife

  • Dr. Erica Mayer, a medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber, explained the concerns over soy consumption and its relationship to breast cancer.

Tags: BreastCancer

  • Dr. Rachel Freedman led a study that found many women with breast cancer may lack knowledge regarding their illness. The findings show how minority patients may be less likely than others to know and report accurate information about their tumors' characteristics.

Tags: PatientEducation, PatientSupport

Showing 11-20 of 607 items